Related Experiment Videos
Prognostic significance of asymptomatic coronary artery disease
Insights
Asymptomatic coronary artery disease may be more dangerous than previously believed. Patients with silent myocardial ischemia or silent myocardial infarctions face risks similar to symptomatic patients, including sudden death or heart attack.
Area of Science:
- Cardiology
- Clinical Medicine
Background:
- Prognosis for asymptomatic coronary artery disease (CAD) is not well-defined.
- Previous assumptions may have underestimated the risks associated with asymptomatic CAD.
Purpose of the Study:
- To clarify the prognosis of various forms of asymptomatic coronary artery disease.
- To highlight the risks in specific patient subgroups with asymptomatic CAD.
Main Methods:
- Review of available data on patients with asymptomatic coronary artery disease.
- Analysis of outcomes in patients with silent myocardial ischemia and silent myocardial infarctions.
Main Results:
- Asymptomatic CAD may not be as benign as previously thought.
- Patients with silent myocardial ischemia, 3-vessel disease, and poor exercise tolerance face risks of sudden death or myocardial infarction.
- Prognosis for silent myocardial infarctions is similar to symptomatic myocardial infarctions.
Conclusions:
- Asymptomatic coronary artery disease, particularly silent myocardial ischemia and silent myocardial infarctions, carries significant risks.
- These conditions require careful consideration and management due to potential severe outcomes.
Abstract:
Prognosis in the various forms of asymptomatic coronary artery disease is not precisely defined but available data suggest that it may not be as benign as previously thought. This is especially true in patients with silent myocardial ischemia, 3-vessel disease and poor exercise tolerance, because many of these patients may go on to sudden death or myocardial infarction. It is also true in patients with silent myocardial infarctions, because prognosis in this type of myocardial infarction is similar to that of patients with symptomatic infarctions.